Empatica
Latest round
- Series B
Last raised
- Nov 2022
Total raised
- Undisclosed
Investors
- 5
About Empatica
, based in Milan, Italy, develops innovative medical devices and AI algorithms for remote patient monitoring and clinical research, enhancing healthcare solutions for various neurological conditions. Empatica Inc. was founded in 2011 in Milan, Italy, and specializes in the creation of medical devices and AI technology for health monitoring. The company was co-founded by Matteo Lai, Michele Simonato, Rosalind Picard, and Simone Tognetti. In October 2025, Empatica acquired PKG Health, a leader in movement disorder algorithms, to expand its capabilities in Parkinson’s disease monitoring. Empatica specializes in advanced medical devices and AI-driven algorithms designed for remote patient monitoring and clinical research. Its flagship offerings include the Empatica Health Monitoring Platform, which integrates the EmbracePlus wearable device and a comprehensive care software suite. The platform is engineered to collect and analyze raw health data and digital biomarkers, facilitating real-time monitoring across various therapeutic areas, including epilepsy and other neurological conditions. With a focus on ease of use, these solutions cater to both clinical environments and everyday life, enabling pharmaceutical companies, contract research organizations, and healthcare providers to enhance patient care and research outcomes. Empatica's products are available in over 160 countries, with extensive localization to support more than 40 languages, thereby ensuring accessibility to a wide array of end users, from patients to trial participants and academic researchers. Following the October 2025 acquisition of PKG Health, Empatica has significantly expanded its revenue potential by integrating PKG’s validated movement disorder algorithms into its platform.S. Following the acquisition, Empatica’s robust, FDA-cleared wearable technology and health monitoring platform with PKG Health’s validated algorithms for movement disorder monitoring, significantly broadening Empatica’s reach and market potential within neurology research, clinical care, and diagnostics. Empatica is focused on expanding its product portfolio and global footprint. The launch of EmbraceMini in 2025 and the CE MDR certification for EpiMonitor in Europe mark key milestones in its growth strategy.
Who invested in Empatica
5 investors across 2 rounds
See all investors in Empatica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Empatica
Who invested in Empatica?
Empatica has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Empatica raised?
Empatica has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Empatica last raise money?
Empatica's most recent round on record is a Series B, in Nov 2022.
What does Empatica do?
, based in Milan, Italy, develops innovative medical devices and AI algorithms for remote patient monitoring and clinical research, enhancing healthcare solutions for various neurological conditions.
Where is Empatica headquartered?
Empatica is headquartered in Milan, Italy.
Which VCs invest in companies like Empatica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Empatica's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Empatica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.